Equilab International, PT was established in November 2002. Through incessant research and innovation this company dedicated to provides services in Bioavailability/Bioequivalence (BA/BE) study and comprehensive Clinical Trial. To fulfill these need, Equilab develops two business area, BA/BE Unit and Clinical Research Unit. As Bioequivalence Studies laboratory, our BA/BE Unit is the first ISO 17025:2017 accredited BA/BE laboratory in Indonesia and offers a lot numbers of bioanalytical capabilities with validated and accredited status. Our Clinical Research Unit provides wide range of clinical trial activities. To support clinical activity, Equilab also have independent clinical laboratory that has been accredited by ISO 15189:2012. We assure you our quality to be your reliable partner in Bioavailability/Bioequivalence studies and Clinical Trials.

PT Equilab International will exhibit in the upcoming CPhI worldwide, 5-7 November 2019 in Messe Frankfurt, Germany. Please drop by our booth (Booth No. 92A30) for a discussion of how Equilab can work with you, our experiences and our capabilities or contact Mr. Ronal (ronal.simanjuntak@equilab-int.com) to arrange a meeting.